Pub Date : 2024-05-17DOI: 10.1080/00952990.2024.2328543
Sarah J. Marks, Huyen Pham, Neil McCray, Jennifer Palazzolo, Ashley Harrell, Jason Lowe, Chethan Bachireddy, Lauren Guerra, Peter J. Cunningham, Andrew J Barnes
Background: Payers are increasingly interested in quality improvement for opioid use disorder (OUD) treatment, including incorporating patient experiences. Medicaid is the largest payer for OUD treatment, yet we know little about the treatment benefits Medicaid members report, how these vary across members, or changed with the COVID-19 pandemic.Objective: To examine Medicaid members' report of outpatient treatment benefits, employment, and housing outcomes before and during the pandemic.Methods: A representative sample of 1,032 Virginia Medicaid members (52% women) receiving OUD treatment completed a survey of treatment benefits, health status and social needs. A reported treatment benefit index was created based on seven self-reported items. Multivariable linear regression models, pooled and stratified by time (pre-COVID-19/COVID-19), assessed member characteristics associated with reported treatment benefit, employment and housing outcomes.Results: Members reported strong treatment benefit (mean: 21.8 [SD: 5.9] out of 28 points) and improvements in employment (2.4 [1.3] out of 5) and housing (2.8 [1.2] out of 5). After adjustment, mental distress (regression coefficient: -3.00 [95% CI:-3.97;-2.03]), polysubstance use (-1.25 [-1.99;-0.51]), and food insecurity (-1.00 [-1.71;-0.29]), were associated with decreased benefits from treatment. During COVID-19, justice-involved individuals reported decreased benefits (-2.17 [-3.54; -0.80]) compared to before the pandemic (-0.09 [-1.4-;1.24] p < .05).Conclusions: Medicaid members receiving outpatient OUD treatment reported positive treatment benefits, and housing and employment outcomes. However, those with comorbid health and social conditions often benefited the least. As payers move toward quality improvement and value-based purchasing initiatives, collecting and integrating patient reported outcomes into quality metrics is critical.
{"title":"Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members.","authors":"Sarah J. Marks, Huyen Pham, Neil McCray, Jennifer Palazzolo, Ashley Harrell, Jason Lowe, Chethan Bachireddy, Lauren Guerra, Peter J. Cunningham, Andrew J Barnes","doi":"10.1080/00952990.2024.2328543","DOIUrl":"https://doi.org/10.1080/00952990.2024.2328543","url":null,"abstract":"Background: Payers are increasingly interested in quality improvement for opioid use disorder (OUD) treatment, including incorporating patient experiences. Medicaid is the largest payer for OUD treatment, yet we know little about the treatment benefits Medicaid members report, how these vary across members, or changed with the COVID-19 pandemic.Objective: To examine Medicaid members' report of outpatient treatment benefits, employment, and housing outcomes before and during the pandemic.Methods: A representative sample of 1,032 Virginia Medicaid members (52% women) receiving OUD treatment completed a survey of treatment benefits, health status and social needs. A reported treatment benefit index was created based on seven self-reported items. Multivariable linear regression models, pooled and stratified by time (pre-COVID-19/COVID-19), assessed member characteristics associated with reported treatment benefit, employment and housing outcomes.Results: Members reported strong treatment benefit (mean: 21.8 [SD: 5.9] out of 28 points) and improvements in employment (2.4 [1.3] out of 5) and housing (2.8 [1.2] out of 5). After adjustment, mental distress (regression coefficient: -3.00 [95% CI:-3.97;-2.03]), polysubstance use (-1.25 [-1.99;-0.51]), and food insecurity (-1.00 [-1.71;-0.29]), were associated with decreased benefits from treatment. During COVID-19, justice-involved individuals reported decreased benefits (-2.17 [-3.54; -0.80]) compared to before the pandemic (-0.09 [-1.4-;1.24] p < .05).Conclusions: Medicaid members receiving outpatient OUD treatment reported positive treatment benefits, and housing and employment outcomes. However, those with comorbid health and social conditions often benefited the least. As payers move toward quality improvement and value-based purchasing initiatives, collecting and integrating patient reported outcomes into quality metrics is critical.","PeriodicalId":501667,"journal":{"name":"The American Journal of Drug and Alcohol Abuse","volume":"22 8","pages":"1-14"},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140963383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-19DOI: 10.1080/00952990.2024.2332597
Emily Pasman, Guijin Lee, Samantha Singer, Nick Burson, Elizabeth Agius, Stella M. Resko
Background: Peer recovery specialists (PRSs) are substance use service providers with lived experience in recovery. Although a large body of research demonstrates the efficacy of medications for op...
{"title":"Attitudes toward medications for opioid use disorder among peer recovery specialists","authors":"Emily Pasman, Guijin Lee, Samantha Singer, Nick Burson, Elizabeth Agius, Stella M. Resko","doi":"10.1080/00952990.2024.2332597","DOIUrl":"https://doi.org/10.1080/00952990.2024.2332597","url":null,"abstract":"Background: Peer recovery specialists (PRSs) are substance use service providers with lived experience in recovery. Although a large body of research demonstrates the efficacy of medications for op...","PeriodicalId":501667,"journal":{"name":"The American Journal of Drug and Alcohol Abuse","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140626267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-19DOI: 10.1080/00952990.2024.2309340
Ofir Livne, Alan Budney, Jacob Borodovsky, Dvora Shmulewitz, Claire Walsh, Cara A. Struble, Mohammad Habib, Efrat Aharonovich, Deborah S. Hasin
Background: Cannabis use is increasing among middle-aged and older US adults, populations that are particularly vulnerable to the adverse effects of cannabis. Risks for adverse effects differ by ca...
{"title":"Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently","authors":"Ofir Livne, Alan Budney, Jacob Borodovsky, Dvora Shmulewitz, Claire Walsh, Cara A. Struble, Mohammad Habib, Efrat Aharonovich, Deborah S. Hasin","doi":"10.1080/00952990.2024.2309340","DOIUrl":"https://doi.org/10.1080/00952990.2024.2309340","url":null,"abstract":"Background: Cannabis use is increasing among middle-aged and older US adults, populations that are particularly vulnerable to the adverse effects of cannabis. Risks for adverse effects differ by ca...","PeriodicalId":501667,"journal":{"name":"The American Journal of Drug and Alcohol Abuse","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140625975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-09DOI: 10.1080/00952990.2024.2308789
Luis Antonio Díaz, Juan Pablo Arab, Lorenzo Leggio
Published in The American Journal of Drug and Alcohol Abuse: Encompassing All Addictive Disorders (Ahead of Print, 2024)
发表于《美国药物与酒精滥用杂志》：囊括所有成瘾性疾病（2024 年提前出版）
{"title":"Granulocyte-colony stimulating factor use in alcohol-associated hepatitis: is it time to promote liver regeneration?","authors":"Luis Antonio Díaz, Juan Pablo Arab, Lorenzo Leggio","doi":"10.1080/00952990.2024.2308789","DOIUrl":"https://doi.org/10.1080/00952990.2024.2308789","url":null,"abstract":"Published in The American Journal of Drug and Alcohol Abuse: Encompassing All Addictive Disorders (Ahead of Print, 2024)","PeriodicalId":501667,"journal":{"name":"The American Journal of Drug and Alcohol Abuse","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140603446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-11DOI: 10.1080/00952990.2023.2289006
Xin Li, Mengsi Xu, Zhenhong Wang
Background: People with substance use disorders (SUDs) who have experienced serious childhood trauma may have executive function impairments contributing to relapse. Baseline respiratory sinus arrh...
{"title":"Childhood trauma, intraindividual reaction time variability, baseline respiratory sinus arrhythmia, and perceived relapse tendency among males with substance use disorders","authors":"Xin Li, Mengsi Xu, Zhenhong Wang","doi":"10.1080/00952990.2023.2289006","DOIUrl":"https://doi.org/10.1080/00952990.2023.2289006","url":null,"abstract":"Background: People with substance use disorders (SUDs) who have experienced serious childhood trauma may have executive function impairments contributing to relapse. Baseline respiratory sinus arrh...","PeriodicalId":501667,"journal":{"name":"The American Journal of Drug and Alcohol Abuse","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138569891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：